Serological Response to Treatment of Syphilis with Doxycycline Compared with Penicillin in HIV-infected Individuals

Kirsten Salado-Rasmussen, Steen Hoffmann, Susan Cowan, Jørgen Skov Jensen, Thomas Benfield, Jan Gerstoft, Terese Lea Katzenstein

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

15 Citationer (Scopus)
469 Downloads (Pure)

Abstract

Serological response to treatment of syphilis with orally administered doxycycline or intramuscularly administered penicillin was assessed in patients with concurrent HIV. All HIV-infected individuals diagnosed with syphilis attending 3 hospitals in Copenhagen, Denmark were included. Odds ratios (ORs) with 95% confidence intervals (CI) associated with serological outcome were modelled using propensity-score-adjusted logistic regression analysis. In total, 202 cases were treated with doxycycline or intramuscular penicillin. At 12 months, serological failure was observed in 12 cases (15%) treated with doxycycline and in 8 cases (17%) treated with penicillin (OR 0.78 (95% CI 0.16-3.88), p = 0.76). The serological cure rate at 12 months was highest in patients with primary syphilis (100%), followed by patients with secondary (89%), early latent (71%) and late latent (67%) syphilis (p = 0.006). In conclusion, this study provides evidence for the use of doxycycline as a treatment option when treating a HIV-infected population for syphilis.

OriginalsprogEngelsk
TidsskriftActa Dermatovenereologica
Vol/bind96
Udgave nummer6
Sider (fra-til)807-811
Antal sider5
ISSN0001-5555
DOI
StatusUdgivet - 2016

Citationsformater